22 March 2000. Mel Feany and Welcome Bender of Harvard Medical School have succeeded in creating a transgenic Drosophila melanogaster model of Parkinson's, and surprisingly, have demonstrated that the flies feature all the hallmarks of the human disease. The researchers inserted a copy of the gene for human alpha-synuclein, a protein that has been linked to a familial form of Parkinson's disease. The flies reached adulthood seemingly normal. But between the ages of 30 and 60 days, the second half of Drosophila's lifespan, the flies lost their dopaminergic neurons, showed α-synuclein containing inclusions (similar to Lewy bodies) in their neurons, and exhibited locomotor dysfunction, all features of human Parkinson's. The damage seems to be selective, as the nervous system in these flies appears to develop normally and there is no widespread cell death in the brains of aged transgenic flies.
"We will now be able to delineate underlying pathogenetic mechanisms and identify novel proteins mediating α-synuclein toxicity in a genetically tractable organism," write the authors. In an accompanying News and Views article, Christian Haass and Philipp Kahle of Ludwig Maximilians University in Munich add that "The short generation time of flies make them invaluable tools for drug screening."-Hakon Heimer.
Reference:Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature 2000 Mar 23;404:394-8. Abstract
Haass C, Kahle PJ. Parkinson's pathology in a fly. Nature 2000 Mar 23;404:341-2. Abstract